CG Oncology
CGON
CGON
121 hedge funds and large institutions have $1.96B invested in CG Oncology in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 61 increasing their positions, 19 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
13% more call options, than puts
Call options by funds: $2.21M | Put options by funds: $1.95M
12.85% more ownership
Funds ownership: 64.94% → 77.79% (+13%)
9% more funds holding
Funds holding: 111 → 121 (+10)
Holders
121
Holding in Top 10
11
Calls
$2.21M
Puts
$1.95M
Top Buyers
| 1 | +$107M | |
| 2 | +$64.8M | |
| 3 | +$60.2M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$27.1M |
| 5 |
O
OrbiMed
New York
|
+$26.1M |
Top Sellers
| 1 | -$53.7M | |
| 2 | -$53.4M | |
| 3 | -$15.8M | |
| 4 |
Walleye Capital
New York
|
-$6.66M |
| 5 |
CF
Corebridge Financial
Houston,
Texas
|
-$6.48M |